ELIZABETH CAMERINO: Open Payments
NPI 1063883593 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,675 in 101 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $281 · 2025 $2,675
Food & beverage: $2,598Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $726 |
| ABBVIE INC. | 17 | $412 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $333 |
| Madrigal Pharmaceuticals | 4 | $245 |
| Novo Nordisk Inc | 3 | $153 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $144 |
| Lilly USA, LLC | 6 | $110 |
| Celltrion USA Inc. | 5 | $98 |
| Mallinckrodt Hospital Products Inc. | 3 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, ENTYVIO, Wegovy, XIFAXAN, OMVOH, VEGZELMA.
Industry payments across PA — which companies pay providers there.
